DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 52 · July 2019 DOI: 10.1055/s-009-43466

Review

Original Paper

175
Minami, Fusaka; Zohar, Joseph; Suzuki, Takefumi; Koizumi, Teruki; Mimura, Masaru; Yagi, Gohei; Uchida, Hiroyuki: Discrepancies Between Nomenclature and Indications of Psychotropics
180
Schennach, Rebecca; Riedel, Michael; Spellmann, Ilja; Musil, Richard; Obermeier, Michael; Jäger, Markus; Bottlender, Roland; Schmauss, Max; Laux, Gerd; Möller, Hans-Jürgen: Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study
186
Kurczewska, Ewa; Ferensztajn-Rochowiak, Ewa; Jasińska-Mikołajczyk, Anna; Chłopocka-Woźniak, Maria; Rybakowski, Janusz K.: Augmentation of Pharmacotherapy by Sleep Deprivation with Sleep Phase Advance in Treatment-Resistant Depression
193
Fountoulakis, Konstantinos N.; Karavelas, Vangelis; Moysidou, Stefania; Mavridis, Dimitris; Pastiadis, Konstantinos; Petalidou, Nicole; Nimatoudis, Ioannis; Kasper, Siegfried: Efficacy of Add-on Pregabalin in the Treatment of Patients with Generalized Anxiety Disorder and Unipolar Major Depression With an Early Nonresponse to Escitalopram: A Double-Blind Placebo-Controlled Study

Letter to the Editor